Statine (French Wikipedia)
Analysis of information sources in references of the Wikipedia article "Statine" in French language version.
Last modified:
Ref.Un. Ref.Website
Global rank
French rank
2,615th place
672nd place
4,430th place
1,799th place
137th place
99th place
1st place
2nd place
3,157th place
998th place
4,716th place
923rd place
low place
730th place
low place
3,531st place
low place
4,173rd place
103rd place
7th place
144th place
12th place
1,078th place
2,371st place
189th place
18th place
4,645th place
low place
low place
1,381st place
low place
5,489th place
60th place
5th place
2,344th place
178th place
6,763rd place
461st place
low place
low place
low place
low place
low place
3,154th place
low place
low place
low place
low place
low place
low place
low place
5,249th place
182nd place
214th place
low place
low place
ahajournals.org (Global: 4,716th place; French: 923rd place)
ahajournals.org
- (en) Grundy SM, Stone NJ, Bailey AL et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Circulation, 2018;138:e1082–e1143.
- (en) Mauricio R, Khera A, Statin use in pregnancy: Is it time for a paradigm shift?, Circulation, 2022;145:496–498.
circ.ahajournals.org
- Krauss RM, Mangravite LM, Smith JD et al. Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment, Circulation, 2008;117:1537–1544.
stroke.ahajournals.org
- (en) Pasternak RC, Smith SC Jr, Bairey-Merz CN et als. ACC/AHA/NHLBI clinical advisory on the use and safety of statins, Stroke, 2002;33:2337-41.
ajconline.org (Global: low place; French: low place)
- (en) Thompson PD, Clarkson PM, Rosenson RS, An assessment of statin safety by muscle experts, Am J Cardiol, 2006;97(suppl):69-76C.
ama-assn.org (Global: 4,430th place; French: 1,799th place)
archinte.ama-assn.org
- (en) Primary prevention of cardiovascular diseases with statin therapy , Paaladinesh Thavendiranathan, Akshay Bagai, M. Alan Brookhart, Niteesh K. Choudhry, Arch Intern Med. 2006;166:2307-2313.
- (en) Joel G. Ray, Muhamad Mamdani, Ross T. Tsuyuki, David R. Anderson, MD, Erik L. Yeo, Andreas Laupacis. « Use of Statins and the Subsequent Development of Deep Vein Thrombosis » Arch Intern Med. 2001;161:1405-1410.
- (en) Tleyjeh IM, Kashour T, Hakim FA et al. « Statins for the prevention and treatment of infections, a systematic review and meta-analysis » Arch Intern Med. 2009;169:1658-1667.
- Hansen KE, Hildebrand JP, Ferguson EE, Stein JH, « Outcomes in 45 patients with statin-associated myopathy », Arch Intern Med, 2005;165:2671-6.
jama.ama-assn.org
- « Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) », JAMA 2001;285:2486-97.
- (en) Statin Therapy and Risks for Death and Hospitalization in Chronic Heart Failure , Alan S. Go, Wendy Y. Lee; Jingrong Yang, Joan C. Lo, Jerry H. Gurwitz, JAMA. 2006;296:2105-2111.
- (en) Philip S. Wang, Daniel H. Solomon, Helen Mogun, Jerry Avorn. « HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients » JAMA. 2000;283:3211-3216.
- Preiss D, Kondapally Seshasai SR, Welsh P et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A meta-analysis, JAMA. 2011;305(24):2556-2564.
annals.org (Global: low place; French: 3,531st place)
- (en) Palmer SC, Craig JC, Navaneethan SD et al. Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review and meta-analysis, Ann Intern Med, 2012;157:263-275.
- (en) Zhang H, Plutzky J, Skentzos Set al. Discontinuation of statins in routine care settings: a cohort study, Ann Intern Med, 2013;158:526-34.
- Patel AM, Shariff S, Bailey DG et al. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study, Ann Intern Med, 2013;158):869-876.
arte.tv (Global: 2,758th place; French: 270th place)
belchol.be (Global: low place; French: low place)
- « Belchol », sur belchol.be (consulté le ).
bmj.com (Global: 1,341st place; French: 480th place)
- (en) Versmissen J, Oosterveer DM, Yazdanpanah M et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study BMJ. 2008;337:a2423.
- (en) Norbert Donner-Banzhoff et Andreas Sönnichsen, « Strategies for prescribing statins », British Medical Journal, vol. 336, no 7639, , p. 288–289 (ISSN 0959-8138 et 1468-5833, PMID 18258935, DOI 10.1136/bmj.39387.573947.80, lire en ligne, consulté le ).
- (en) Anthony Matthews, Emily Herrett, Antonio Gasparrini, Tjeerd Van Staa, Ben Goldacre, Liam Smeeth et Krishnan Bhaskaran, « Impact of statin related media coverage on use of statins : interrupted time series analysis with UK primary care data », British Medical Journal, no 353, (DOI 10.1136/bmj.i3283, lire en ligne).
- (en) Van den Hoek HL, Bos WJW, De Boer A, van de Garde EMW. « Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials » BMJ 2011;343:d7281.
- (en) Sumit R Majumdar, Finlay A McAlister, Dean T Eurich, Raj S Padwal, Thomas J Marrie. « Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study » BMJ 2006;333:999.
- (en) Bateman BT, Hernandez-Diaz S, Fischer MA, Seely EW et al. Statins and congenital malformations: cohort study, BMJ, 2015;350:h1035.
- (en) Sathasivam S, Lecky B, « Statin induced myopathy » BMJ, 2008;337:a2286
- (en) Hippisley-Cox J, Coupland C, Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database, BMJ, 2010;340:c2197
cbip.be (Global: low place; French: 7,259th place)
chestjournal.org (Global: low place; French: low place)
- (en) Khurana V, Bejjanki HR, Caldito G, Owens MW. « Statins reduce the risk of lung cancer in humans: A large case-control study of US veterans » Chest. 2007; 131:1282-1288
cochrane.org (Global: low place; French: 5,489th place)
www2.cochrane.org
- (en) Taylor F, Ward K, Moore THM et Als. Statins for the primary prevention of cardiovascular disease'', Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD004816. DOI: 10.1002/14651858.CD004816.pub4.
doi.org (Global: 2nd place; French: 3rd place)
dx.doi.org
- (en) Akira Endo, Masao Kuroda et Yoshio Tsujita, « ML-236A, ML-236B, AND ML-236C, NEW INHIBITORS OF CHOLESTEROGENESIS PRODUCED BY PENICILLIUM CITRINUM », The Journal of Antibiotics, vol. 29, no 12, , p. 1346–1348 (ISSN 0021-8820 et 1881-1469, DOI 10.7164/antibiotics.29.1346, lire en ligne, consulté le )
- (en) Norbert Donner-Banzhoff et Andreas Sönnichsen, « Strategies for prescribing statins », British Medical Journal, vol. 336, no 7639, , p. 288–289 (ISSN 0959-8138 et 1468-5833, PMID 18258935, DOI 10.1136/bmj.39387.573947.80, lire en ligne, consulté le ).
- (en) Anthony Matthews, Emily Herrett, Antonio Gasparrini, Tjeerd Van Staa, Ben Goldacre, Liam Smeeth et Krishnan Bhaskaran, « Impact of statin related media coverage on use of statins : interrupted time series analysis with UK primary care data », British Medical Journal, no 353, (DOI 10.1136/bmj.i3283, lire en ligne).
- (en) Roger Chou, Amy Cantor, Tracy Dana et Jesse Wagner, « Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force », JAMA, vol. 328, no 8, , p. 754 (ISSN 0098-7484, DOI 10.1001/jama.2022.12138, lire en ligne, consulté le ).
- (en) European Food Safety Authority (EFSA). « Scientific Opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 » EFSA Journal 2011;9(7):2304. DOI 10.2903/j.efsa.2011.2304.
- (en) Ulrich Laufs, Hubert Scharnagl, Martin Halle et Eberhard Windler, « Treatment Options for Statin-Associated Muscle Symptoms », Deutsches Arzteblatt International, vol. 112, no 44, , p. 748–755 (ISSN 1866-0452, PMID 26575138, PMCID 4650909, DOI 10.3238/arztebl.2015.0748, lire en ligne, consulté le ).
- (en) Ting Cai, Jennifer A. Hirst, Brian D. Nicholson et Richard J. McManus, « Predicting the risk of serious muscle disorders in individuals eligible for statin treatment in England: derivation and validation of a clinical prediction model », The Lancet Digital Health, vol. 0, no 0, (ISSN 2589-7500, PMID 42350256, DOI 10.1016/j.landig.2026.101024, lire en ligne, consulté le )
- (en) Gunnar Weninger, Haikel Dridi, Steven Reiken et Qi Yuan, « Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation », The Journal of Clinical Investigation, vol. 135, no 24, (ISSN 0021-9738, DOI 10.1172/JCI194490, lire en ligne, consulté le )
epidem.com (Global: low place; French: low place)
- (en) Gaist D, Rodríguez LA, Huerta C, Hallas J, Sindrup SH, Lipid-lowering drugs and the risk of myopathy: a population-based follow-up study, Epidemiology, 2001;12:565-9
europa.eu (Global: 62nd place; French: 68th place)
efsa.europa.eu
- (en) European Food Safety Authority (EFSA). « Scientific Opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 » EFSA Journal 2011;9(7):2304. DOI 10.2903/j.efsa.2011.2304.
googleusercontent.com (Global: 144th place; French: 12th place)
webcache.googleusercontent.com
has-sante.fr (Global: low place; French: 730th place)
issn.org (Global: 33rd place; French: 4th place)
portal.issn.org
- (en) Akira Endo, Masao Kuroda et Yoshio Tsujita, « ML-236A, ML-236B, AND ML-236C, NEW INHIBITORS OF CHOLESTEROGENESIS PRODUCED BY PENICILLIUM CITRINUM », The Journal of Antibiotics, vol. 29, no 12, , p. 1346–1348 (ISSN 0021-8820 et 1881-1469, DOI 10.7164/antibiotics.29.1346, lire en ligne, consulté le )
- (en) Norbert Donner-Banzhoff et Andreas Sönnichsen, « Strategies for prescribing statins », British Medical Journal, vol. 336, no 7639, , p. 288–289 (ISSN 0959-8138 et 1468-5833, PMID 18258935, DOI 10.1136/bmj.39387.573947.80, lire en ligne, consulté le ).
- (en) Roger Chou, Amy Cantor, Tracy Dana et Jesse Wagner, « Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force », JAMA, vol. 328, no 8, , p. 754 (ISSN 0098-7484, DOI 10.1001/jama.2022.12138, lire en ligne, consulté le ).
- (en) Lukas Zlatohlavek, Michal Vrablik, Barbora Grauova et Eva Motykova, « The effect of coenzyme Q10 in statin myopathy », Neuro Endocrinology Letters, vol. 33 Suppl 2, , p. 98–101 (ISSN 0172-780X, PMID 23183519, lire en ligne, consulté le ).
- (en) Ulrich Laufs, Hubert Scharnagl, Martin Halle et Eberhard Windler, « Treatment Options for Statin-Associated Muscle Symptoms », Deutsches Arzteblatt International, vol. 112, no 44, , p. 748–755 (ISSN 1866-0452, PMID 26575138, PMCID 4650909, DOI 10.3238/arztebl.2015.0748, lire en ligne, consulté le ).
- (en) Ting Cai, Jennifer A. Hirst, Brian D. Nicholson et Richard J. McManus, « Predicting the risk of serious muscle disorders in individuals eligible for statin treatment in England: derivation and validation of a clinical prediction model », The Lancet Digital Health, vol. 0, no 0, (ISSN 2589-7500, PMID 42350256, DOI 10.1016/j.landig.2026.101024, lire en ligne, consulté le )
- (en) Gunnar Weninger, Haikel Dridi, Steven Reiken et Qi Yuan, « Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation », The Journal of Clinical Investigation, vol. 135, no 24, (ISSN 0021-9738, DOI 10.1172/JCI194490, lire en ligne, consulté le )
jamanetwork.com (Global: 3,157th place; French: 998th place)
jama.jamanetwork.com
- (en) Chasman DI, Posada D, Subrahmanyan L et al. Pharmacogenetic study of statin therapy and cholesterol reduction, JAMA, 2004;291:2821–2827
- Klein BE, Klein R, Lee KE, Grady LM, Statin use and incident nuclear cataract, JAMA, 2006;295:2752-8.
- Cholesterol-lowering drugs taken by 28% of US population, JAMA, 2015;313:787.
jamanetwork.com
- (en) Roger Chou, Amy Cantor, Tracy Dana et Jesse Wagner, « Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force », JAMA, vol. 328, no 8, , p. 754 (ISSN 0098-7484, DOI 10.1001/jama.2022.12138, lire en ligne, consulté le ).
jci.org (Global: low place; French: 4,519th place)
- (en) Gunnar Weninger, Haikel Dridi, Steven Reiken et Qi Yuan, « Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation », The Journal of Clinical Investigation, vol. 135, no 24, (ISSN 0021-9738, DOI 10.1172/JCI194490, lire en ligne, consulté le )
jco.org (Global: low place; French: low place)
- (en) The Risk of Cancer in Users of Statins, Matthijs R. Graaf, Annette B. Beiderbeck, Antoine C.G. Egberts, Dick J. Richel, Henk-Jan Guchelaar, Journal of Clinical Oncology, Vol 22, No 12 (June 15), 2004: p. 2388-2394
jst.go.jp (Global: 1,248th place; French: 1,990th place)
jstage.jst.go.jp
- (en) Akira Endo, Masao Kuroda et Yoshio Tsujita, « ML-236A, ML-236B, AND ML-236C, NEW INHIBITORS OF CHOLESTEROGENESIS PRODUCED BY PENICILLIUM CITRINUM », The Journal of Antibiotics, vol. 29, no 12, , p. 1346–1348 (ISSN 0021-8820 et 1881-1469, DOI 10.7164/antibiotics.29.1346, lire en ligne, consulté le )
latribune.fr (Global: 2,344th place; French: 178th place)
- « Malgré l'affaire Mediator, Servier reste (trop) proche des cardiologues », sur La Tribune (consulté le ) : « Elle est financée en partie grâce aux partenariats noués avec les laboratoires pharmaceutiques, dont Servier ».
lemonde.fr (Global: 60th place; French: 5th place)
- Paul Benkimoun et Sandrine Cabut, « Les tontons flingueurs du médicament », Le Monde, (lire en ligne, consulté le ).
liberation.fr (Global: 189th place; French: 18th place)
- « Qu'en est-il de la polémique sur le cholestérol et les statines? », sur Libération (consulté le )
liguecardioliga.be (Global: low place; French: low place)
- « Ligue cardiologique belge – Soutenez la ligue ! » (consulté le ).
medscape.com (Global: 1,078th place; French: 2,371st place)
francais.medscape.com
- Société française de cardiologie, « Cholestérol et maladies cardiovasculaires : le point de vue scientifique de la Société française de cardiologie », sur medscape.com, Medscape France, (consulté le ).
nejm.org (Global: 2,717th place; French: 434th place)
nejm.org
- (en) Keaney JF, Curfman G, Jarcho JA, « A pragmatic view of the new cholesterol treatment guidelines » N Eng J Med, 2013.
- (en) Mammen AL, Statin-associated autoimmune myopathy, N Engl J Med, 2016;374:664-669.
content.nejm.org
- (en) Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK, Rennert G. « Statins and the risk of colorectal cancer » N Engl J Med. 2005;352:2184-92.
- (en) The SEARCH Collaborative Group, « SLCO1B1 variants and statin-induced myopathy — A genomewide study » New Eng J Med, 2008;359:789-799.
nih.gov (Global: 5th place; French: 11th place)
ncbi.nlm.nih.gov
- (en) Smith MEB, Lee NJ, Haney E, Carson S, Drug class review: HMG-CoA reductase inhibitors (statins) and fixed-dose combination products containing a statin. Final report, Update 5. Portland: Oregon Health & Science University, November 2009.
- (en) Norbert Donner-Banzhoff et Andreas Sönnichsen, « Strategies for prescribing statins », British Medical Journal, vol. 336, no 7639, , p. 288–289 (ISSN 0959-8138 et 1468-5833, PMID 18258935, DOI 10.1136/bmj.39387.573947.80, lire en ligne, consulté le ).
- (en) Lukas Zlatohlavek, Michal Vrablik, Barbora Grauova et Eva Motykova, « The effect of coenzyme Q10 in statin myopathy », Neuro Endocrinology Letters, vol. 33 Suppl 2, , p. 98–101 (ISSN 0172-780X, PMID 23183519, lire en ligne, consulté le ).
- (en) Ulrich Laufs, Hubert Scharnagl, Martin Halle et Eberhard Windler, « Treatment Options for Statin-Associated Muscle Symptoms », Deutsches Arzteblatt International, vol. 112, no 44, , p. 748–755 (ISSN 1866-0452, PMID 26575138, PMCID 4650909, DOI 10.3238/arztebl.2015.0748, lire en ligne, consulté le ).
- (en) Ting Cai, Jennifer A. Hirst, Brian D. Nicholson et Richard J. McManus, « Predicting the risk of serious muscle disorders in individuals eligible for statin treatment in England: derivation and validation of a clinical prediction model », The Lancet Digital Health, vol. 0, no 0, (ISSN 2589-7500, PMID 42350256, DOI 10.1016/j.landig.2026.101024, lire en ligne, consulté le )
- (en) C.R. Dormuth et al., « Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases », British medical journal, vol. 346, no f880, (PMID 23511950, lire en ligne, consulté le ).
- (en) Collins R, Armitage J, Parish S, Sleight P, Peto R, Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions, Lancet, 2004:363;757–767.
- (en) Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 1992;33:1569-82. .
pubmed.ncbi.nlm.nih.gov
- (en) Lukas Zlatohlavek, Michal Vrablik, Barbora Grauova et Eva Motykova, « The effect of coenzyme Q10 in statin myopathy », Neuro Endocrinology Letters, vol. 33 Suppl 2, , p. 98–101 (ISSN 0172-780X, PMID 23183519, lire en ligne, consulté le ).
- (en) Ulrich Laufs, Hubert Scharnagl, Martin Halle et Eberhard Windler, « Treatment Options for Statin-Associated Muscle Symptoms », Deutsches Arzteblatt International, vol. 112, no 44, , p. 748–755 (ISSN 1866-0452, PMID 26575138, PMCID 4650909, DOI 10.3238/arztebl.2015.0748, lire en ligne, consulté le ).
onlinejacc.org (Global: low place; French: 4,173rd place)
content.onlinejacc.org
- (en) Giraldez RR, Giugliano RP, Mohanavelu S. et al. « Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: A PROVE ITTIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection TherapyThrombolysis In Myocardial Infarction 22) Analysis » JACC 2008;52:914-920.
- (en) Voora D, Ginsburg GS, Clinical Application of Cardiovascular Pharmacogenetics, J Am Coll Cardiol, 2012;60:9-20
- (en) Alpert MA, « Do statins reduce the risk of contrast-induced acute kidney injury in patients undergoing coronary angiography or percutaneous coronary interventions? » J Am Coll Cardiol, 2014;63:80-82.
oup.com (Global: 292nd place; French: 279th place)
academic.oup.com
- Farmakis I, Christodoulou KC, Hobohm L et al. Lipid lowering for prevention of venous thromboembolism: a network meta-analysis, Europ Heart J, 2024;45:3219–3227
passeportsante.net (Global: low place; French: 1,381st place)
- Levure de riz rouge, sur le site passeportsante.net, consulté le 25 octobre 2013.
pourquoidocteur.fr (Global: low place; French: 5,249th place)
- pourquoidocteur.fr, « Statines : l’étude qui rassure sur les effets secondaires sur les muscles », sur www.pourquoidocteur.fr, (consulté le )
pseudo-sciences.org (Global: low place; French: 3,154th place)
- « Quand Arte nous trompe sur le cholestérol », sur pseudo-sciences.org.
reporterre.net (Global: 6,763rd place; French: 461st place)
- « Opération Mains propres sur la santé publique : stop à la corruption », sur Reporterre, le quotidien de l'écologie (consulté le ) : « Enfin, les liens avec l’industrie pharmaceutique concernent aussi les associations à l’instar de la Société française de cardiologie financée par Sanofi-Aventis ».
rtl.be (Global: 4,586th place; French: 354th place)
- « Le taux de cholestérol élevé, vraiment mauvais pour la santé ? Un docu dénonce un grand bluff, et INDIGNE de nombreux médecins », sur RTL, (consulté le ).
- Olivier Descamps, « Polémique, intolérance, non adhérence et autres contrariétés autour de la prescription des statines. Comment y faire face ? », Louvain Medical, vol. 135, no 9, , p. 600-608 (lire en ligne).
sante.fr (Global: 9,854th place; French: 723rd place)
ansm.sante.fr
sciencedirect.com (Global: 137th place; French: 99th place)
- (en) Puri R, Nicholls SJ, Shao M et al. Impact of statins on serial coronary calcification during atheroma progression and regression, J Am Coll Cardiol, 2015;65:1273–1282.
- (en) Iakoubova OA, Sabatine MS, Rowland CW et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study, J Am Coll Cardiol, 2008;51:449–455
- (en) Assimes TL, Hólm H, Kathiresan S et al. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies, J Am Coll Cardiol, 2010;56:1552–1563.
- (en) Hopewell JC, Parish S, Clarke R et al. No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the Heart Protection Study, J Am Coll Cardiol. 2011;57:2000–2007.
- (en) Shepherd J, Blauw GJ, Murphy MB et al. Pravastatin in Elderly Individuals at Risk of Vascular Disease (PROSPER): a randomised controlled trial'', Lancet, 2002:360;1623–1630.
- Blaha MJ, Martin SS, How do statins work? Changing paradigms with implications for statin allocation, J Am Coll Cardiol, 2013;62:2392-4.
springer.com (Global: 182nd place; French: 214th place)
link.springer.com
- Bailey DG, Dresser GK, Interactions between grapefruit juice and cardiovascular drugs, Am J Cardiovasc Drugs, 2004;4:281–297.
thelancet.com (Global: 2,615th place; French: 672nd place)
- (en) Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170000 participants in 26 randomised trials, Lancet, 2010;376:1670-1681
- (en) Armitage J, The safety of statins in clinical practice, Lancet, 2007;370:1781-1790.
- (en) H Jick, GL Zornberg, SS Jick, S Seshadri, DA Drachman. « Statins and the risk of dementia » Lancet 2000; 356:1627-1631
- (en) Ting Cai, Jennifer A. Hirst, Brian D. Nicholson et Richard J. McManus, « Predicting the risk of serious muscle disorders in individuals eligible for statin treatment in England: derivation and validation of a clinical prediction model », The Lancet Digital Health, vol. 0, no 0, (ISSN 2589-7500, PMID 42350256, DOI 10.1016/j.landig.2026.101024, lire en ligne, consulté le )
- (en) Athyros VG, Tziomalos K, Gossios TD et Als, for the GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis, Lancet, 2010;376:1916-1922.
- Sattar N, Preiss D, Murray HM et als. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials, Lancet, 2010;375: 735-734.
trialsjournal.com (Global: low place; French: low place)
- (en) Furberg CD, Pitt B, Withdrawal of cerivastatin from the world market, Curr Control Trials, Cardiovasc Med, 2001:2;205–207.
uptodate.com (Global: 4,645th place; French: low place)
- (en) Robert S Rosenson, « Statins: Actions, side effects, and administration »
, sur www.uptodate.com, (consulté le )
vidal.fr (Global: low place; French: 1,084th place)
- Jean-Philippe Rivière, « Statines : utilité revue à la hausse dans The Lancet, mais des points importants restent contestés ».
web.archive.org (Global: 1st place; French: 2nd place)
- « arte.tv/guide/fr/051063-000-A/… »(Archive.org • Wikiwix • Google • Que faire ?).
- « Compléments alimentaires à base de levure de riz rouge : mises en garde de l’ANSM - Point d'information »(Archive.org • Wikiwix • Google • Que faire ?) .
- Isabelle Lacroix, Levure de riz rouge, une statine cachée, Dictionnaire Français du Médicament.
wikiwix.com (Global: 103rd place; French: 7th place)
archive.wikiwix.com
wiley.com (Global: 150th place; French: 129th place)
onlinelibrary.wiley.com
- Taylor F, Huffman MD, Macedo AF, Moore THM et al. Statins for the primary prevention of cardiovascular disease, Cochrane Database Syst Rev, 2013;1:CD004816
- (en) Manktelow BN, Potter JF. Interventions in the management of serum lipids for preventing stroke recurrence, Cochrane Database Syst Rev, 2009;CD002091.